期刊的影响因子--文章列表

期刊文章列表
Yanping Wu^1,2,3,4，Xiang Luo^1,2,3，Qingqing Zhou^1,2,3，Haibiao Gong^1,2,3，Huaying Gao^1,2,3，Tongzheng Liu⁵，Jiaxu Chen^6,4，Lei Liang^1,2,3,4，Hiroshi Kurihara^1,2,3，Yi-Fang Li^1,2,3，Rong-Rong He^1,2,3,4（Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility，Jinan University；International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education，College of Pharmacy，Jinan University；Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research，College of Pharmacy，Jinan University；Integrated Chinese and Western Medicine Postdoctoral Research Station，Jinan University；Institute of Tumor Pharmacology，College of Pharmacy，Jinan University；Formula-pattern Research Center，School of Traditional Chinese Medicine，Jinan University）.The disbalance of LRP1 and SIRPα by psychological stress dampens the clearance of tumor cells by macrophages[J].Acta Pharmaceutica Sinica B,2022,第1期 Rui Li¹，Li Xie¹，Lei Li¹，Xiaojiao Chen²，Tong Yao¹，Yuanxin Tian³，Qingping Li⁴，Kai Wang⁴，Chenyang Huang¹，Cui Li¹，Yifan Li¹，Hongwei Zhou²，Neil Kaplowitz⁵，Yong Jiang¹，Peng Chen^1,2（Department of Pathophysiology，Guangdong Provincial Key Laboratory of Proteomics，School of Basic Medical Sciences，Southern Medical University；Microbiome Medicine Center，Zhujiang Hospital，Southern Medical University；Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Science，Southern Medical University；Division of Hepatobiliopancreatic Surgery，Department of General Surgery，Nanfang Hospital，Southern Medical University；USC Research Center for Liver Disease，Department of Medicine，Keck School of Medicine of USC）.The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice[J].Acta Pharmaceutica Sinica B,2022,第1期 Xianbin Ma¹，Shaochen Yang²，Tian Zhang¹，Shuo Wang²，Qichao Yang²，Yao Xiao²，Xiaoxiao Shi³，Peng Xue¹，Yuejun Kang¹，Gang Liu³，Zhi-Jun Sun²，Zhigang Xu¹（Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University)，Ministry of Education，School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices，Southwest University；The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine，Ministry of Education，School and Hospital of Stomatology，Wuhan University；State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine，School of Public Health，Xiamen University）.Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第1期 Lei Luo¹，Yiming Qi¹，Hong Zhong¹，Shinan Jiang¹，Hu Zhang²，Hao Cai³，Yahui Wu³，Zhongwei Gu³，Qiyong Gong^3,4，Kui Luo³（College of Pharmaceutical Sciences，Southwest University；Amgen Bioprocessing Centre，Keck Graduate Institute；Huaxi MR Research Center (HMRRC)，Department of Radiology，Functional and Molecular Imaging Key Laboratory of Sichuan Province，National Clinical Research Center for Geriatrics，West China Hospital，Sichuan University；Research Unit of Psychoradiology，Chinese Academy of Medical Sciences）.GSH-sensitive polymeric prodrug：Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine[J].Acta Pharmaceutica Sinica B,2022,第1期 Zhenhao Tian^1,2,3，Fei Yan¹，Xiangge Tian^1,2，Lei Feng^1,4，Jingnan Cui⁵，Sa Deng¹，Baojing Zhang¹，Tian Xie⁶，Shanshan Huang¹，Xiaochi Ma^1,2（Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention，The Second Affiliated Hospital，College of Integrative Medicine，College of Pharmacy，Dalian Medical University；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；School of Life Sciences，Northwestern Polytechnical University；School of Chemistry and Chemical Engineering，Henan Normal University；State Key Laboratory of Fine Chemicals，Dalian University of Technology；College of Pharmacy，Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines，Hangzhou Normal University）.A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis,and the development of inhibitor[J].Acta Pharmaceutica Sinica B,2022,第1期 Yuanyuan Wang^1,2，Bin Wei^1,3，Danping Wang^1,2，Jingjing Wu³，Jianhua Gao⁴，Haiqing Zhong⁴，Yang Sun⁴，Qiang Xu⁴，Wen Liu⁴，Yanhong Gu^1,2，Wenjie Guo⁴（Department of Oncology，the First Affiliated Hospital of Nanjing Medical University；Cancer Rehabilitation Center，Jiangsu Province Hospital；Department of Oncology，the Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University；State Key Laboratory of Pharmaceutical Biotechnology，School of Life Sciences，Nanjing University）.DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS-STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis[J].Acta Pharmaceutica Sinica B,2022,第1期 Jian Gao¹，Zhigui Wu¹，Mingxia Zhao^1,2，Rui Zhang³，Manru Li¹，Dongdong Sun⁴，Haibo Cheng⁴，Xianjia Qi⁵，Yuxian Shen²，Qiang Xu^1,6，Hongqi Chen⁷，Dijun Chen¹，Yang Sun^1,6（State Key Laboratory of Pharmaceutical Biotechnology，Chemistry and Biomedicine Innovation Center(Chem BIC)，School of Life Sciences，Nanjing University；Biopharmaceutical Research Institute，School of Basic Medical Sciences，Anhui Medical University；Department of Colorectal Surgery，Cancer Hospital of China Medical University，Liaoning Cancer Hospital & Institute；The First Clinical College of Nanjing University of Chinese Medicine；Shanghai Xu Ran Biotechnology Co.，Ltd.；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；Department of General Surgery，Shanghai Jiao Tong University Affiliated Sixth People's Hospital）.Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics[J].Acta Pharmaceutica Sinica B,2022,第1期 Junxia Wang，Minghua Chen，Mengyan Wang，Wenxia Zhao，Conghui Zhang，Xiujun Liu，Meilian Cai，Yuhan Qiu，Tianshu Zhang，Huimin Zhou，Wuli Zhao，Shuyi Si，Rongguang Shao（Key Laboratory of Antibiotic Bioengineering，Ministry of Health，Laboratory of Oncology，Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP via ER stress in pancreatic cancer cells[J].Acta Pharmaceutica Sinica B,2022,第1期 Shuangquan Gou^1,2,3，Nanxi Chen²，Xiaoai Wu⁴，Menghang Zu^2,3，Shixiong Yi²，Binwu Ying⁵，Fangyin Dai²，Bowen Ke¹，Bo Xiao^2,3（Laboratory of Anesthesiology & Critical Care Medicine，Department of Anesthesiology，West China Hospital，Sichuan University；State Key Laboratory of Silkworm Genome Biology，College of Sericulture，Textile and Biomass Sciences，Southwest University；Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing，School of Materials and Energy，Southwest University；Department of Nuclear Medicine，West China Hospital，Sichuan University；Department of Laboratory Medicine，West China Hospital，Sichuan University）.Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第1期 Tuo Shao^1,2，Zhen Chen¹，Jian Rong¹，Vasily Belov^1,3，Jiahui Chen¹，Andre Jeyarajan²，Xiaoyun Deng¹，Hualong Fu¹，Qingzhen Yu¹，Steve H.Rwema²，Wenyu Lin²，Mikhail Papisov^1,3，Lee Josephson¹，Raymond T.Chung²，Steven H.Liang¹（Division of Nuclear Medicine and Molecular Imaging，Department of Radiology，Massachusetts General Hospital and Harvard Medical School；Liver Center and Gastrointestinal Division，Department of Medicine，Massachusetts General Hospital，Harvard Medical School；Shriners Hospitals for Children-Boston Boston）.[¹⁸F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models[J].Acta Pharmaceutica Sinica B,2022,第1期 Qi Hu^1,2，Lanlan Jia^1,2，Xiaolin Zhang^1,2，Aihong Zhu^1,2，Sicen Wang^1,2，Xiaoyu Xie^1,2（School of Pharmacy，Health Science Center，Xi'an Jiaotong University；Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis）.Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine[J].Acta Pharmaceutica Sinica B,2022,第1期 Yingtong Cui^1,2，Ying Huang^1,2，Xuejuan Zhang^1,2，Xiangyun Lu³，Jun Xue⁴，Guanlin Wang²，Ping Hu¹，Xiao Yue²，Ziyu Zhao^2,5，Xin Pan²，Chuanbin Wu^1,2（School of Pharmaceutical Science，Jinan University；School of Pharmaceutical Sciences，Sun Yat-sen University；Micromeritics Instrument (Shanghai) Ltd.；MEGGLE Group Shanghai Representative Office；Department of Pharmacology，Zhongshan School of Medicine，Sun Yat-sen University）.A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes[J].Acta Pharmaceutica Sinica B,2022,第1期 Zhangxu He¹，Haomiao Jiao¹，Qi An¹，Xin Zhang¹，Dan Zengyangzong¹，Jiale Xu¹，Hongmin Liu¹，Liying Ma^1,2，Wen Zhao¹（State Key Laboratory of Esophageal Cancer Prevention and Treatment，Key Laboratory of Advanced Pharmaceutical Technology，Ministry of Education of China，School of Pharmaceutical Sciences，Zhengzhou University；China Meheco Topfond Pharmaceutical Co）.Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis[J].Acta Pharmaceutica Sinica B,2022,第1期 Cong Liu¹，Anzhi Hu¹，Huijuan Chen¹，Jing Liang²，Mancang Gu¹，Yang Xiong¹，Chao-Feng Mu^1,3（School of Pharmaceutical Sciences，Zhejiang Chinese Medical University；Center for Synthetic Biochemistry，Shenzhen Institute of Synthetic Biology，Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences；Engineering Research Center of Clinical Functional Materials and Diagnosis & Treatment Devices of Zhejiang Province，Wenzhou Institute of Biomaterials and Engineering）.The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone[J].Acta Pharmaceutica Sinica B,2022,第1期 Rong Guo，Miao Deng，Xuan He，Mengmeng Li，Jiaxin Li，Penghui He，Houqin Liu，Man Li，Zhirong Zhang，Qin He（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment[J].Acta Pharmaceutica Sinica B,2022,第1期 Lei Fang^1,2，Zitong Zhao²，Jue Wang²，Ping Xiao²，Xiangshi Sun²，Yaping Ding¹，Pengcheng Zhang^2,3，Dangge Wang^2,4,3，Yaping Li^2,4,3（Collage of Sciences，Shanghai University；State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Yantai Key Laboratory of Nanomedicine & Advanced Preparations，Yantai Institute of Materia Medica；School of Pharmacy，Yantai University）.Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer[J].Acta Pharmaceutica Sinica B,2022,第1期 Chen Chen，Tianyu Zhu，Xiaoqin Liu，Dongrong Zhu，Yi Zhang，Sifang Wu，Chao Han，Hao Zhang，Jianguang Luo，Lingyi Kong（Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines，School of Traditional Chinese Pharmacy，China Pharmaceutical University）.Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling[J].Acta Pharmaceutica Sinica B,2022,第1期 Wenjuan Liu¹，Zhenqiang Li¹，Simeng Chu¹，Xiaoyao Ma¹，Xiaoying Wang²，Min Jiang¹，Gang Bai¹（State Key Laboratory of Medicinal Chemical Biology，College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research，Nankai University；Tianjin University of Traditional Chinese Medicine）.Atractylenolide-I covalently binds to CYP11B2,selectively inhibits aldosterone synthesis, and improves hyperaldosteronism[J].Acta Pharmaceutica Sinica B,2022,第1期 Heng Li^1,2，Yao Zhang³，Moting Liu^1,2，Chen Fan¹，Chunlan Feng¹，Qiukai Lu^1,2，Caigui Xiang^1,2，Huimin Lu^1,2，Xiaoqian Yang¹，Bing Wu^1,2，Duowu Zou³，Wei Tang^1,2（Laboratory of Anti-inflammation and Immunopharmacology，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmacy，University of Chinese Academy of Sciences；Department of Gastroenterology，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine）.Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis[J].Acta Pharmaceutica Sinica B,2022,第1期 Long Xi¹，Zibei Lin¹，Fen Qiu¹，Shaokui Chen¹，Ping Li²，Xin Chen¹，Zhenping Wang³，Ying Zheng¹（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；Beijing Hospital of Traditional Chinese Medicine，Affiliated with Capital Medical University；Department of Dermatology，School of Medicine，University of California）.Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment[J].Acta Pharmaceutica Sinica B,2022,第1期 Long Chen¹，Jing Zhang²，Xinjing Wang^3,4，Yu Li¹，Lu Zhou⁵，Xiongxiong Lu^3,4，Guoqiang Dong¹，Chunquan Sheng¹（School of Pharmacy，Second Military Medical University；Department of Pathology，Changzheng Hospital，Second Military Medical University；Department of General Surgery，Pancreatic Disease Center，Ruijin Hospital，Shanghai Jiao Tong University；Research Institute of Pancreatic Diseases，Shanghai Jiao Tong University School of Medicine；Department of Medicinal Chemistry，School of Pharmacy，Fudan University）.Discovery of novel KRAS-PDEδ inhibitors with potent activity in patient-derived human pancreatic tumor xenograft models[J].Acta Pharmaceutica Sinica B,2022,第1期 Hongyu Sun^1,2，Siyu He^2,3，Li Wu²，Zeying Cao^2,3，Xian Sun^2,3,4，Mingwei Xu⁵，Shan Lu^2,6，Mingdi Xu⁷，Baoming Ning⁷，Huimin Sun^8,7，Tiqiao Xiao⁵，Peter York²，Xu Xu¹，Xianzhen Yin^2,4，Jiwen Zhang^1,2,8（School of Chemical and Environmental Engineering，Shanghai Institute of Technology；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Center for MOST and Image Fusion Analysis，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Shanghai Synchrotron Radiation Facility/Zhangjiang Lab，Shanghai Advanced Research Institute，Chinese Academy of Sciences；School of Materials Science and Engineering，Center for Supramolecular Chemistry and Catalysis，Department of Chemistry，Shanghai University；National Institutes for Food and Drug Control；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients，National Institutes for Food and Drug Control）.Bridging the structure gap between pellets in artificial dissolution media and in gastro-intestinal tract in rats[J].Acta Pharmaceutica Sinica B,2022,第1期 Benyu Nan^1,2，Zirui Zhao³，Kanglun Jiang¹，Xi Gu⁴，Huawei Li^5,6,7,8，Xinsheng Huang¹（Department of Otorhinolaryngology-Head and Neck Surgery，Zhongshan Hospital，Fudan University；Department of Otorhinolaryngology-Head and Neck Surgery，Wenzhou Medical University，Affiliated Hospital 2；Department of Otolaryngology，Yueyang Hospital of Integrated Traditional Chinese and Western Medicine，Shanghai University of Traditional Chinese Medicine；Department of Otolaryngology，the First Affiliated Hospital of Fujian Medical University；ENT Institute and Department of Otorhinolaryngology，Eye & ENT Hospital，State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science，Fudan University；Institutes of Biomedical Sciences，Fudan University；NHC Key Laboratory of Hearing Medicine (Fudan University)；The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science，Fudan University）.Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo[J].Acta Pharmaceutica Sinica B,2022,第1期 Liang Chen¹，Jie Zhang¹，Zhun Lin¹，Ziyan Zhang¹，Miao Mao¹，Jiacheng Wu¹，Qian Li^2,3，Yuanqing Zhang¹，Chunhai Fan^2,3（School of Pharmaceutical Sciences，Sun Yat-sen University；School of Chemistry and Chemical Engineering，Frontiers Science Center for Transformative Molecules and National Center for Translational Medicine，Shanghai Jiao Tong University；Institute of Molecular Medicine，Shanghai Key Laboratory for Nucleic Acids Chemistry and Nanomedicine，Renji Hospital，School of Medicine，Shanghai Jiao Tong University）.Pharmaceutical applications of framework nucleic acids[J].Acta Pharmaceutica Sinica B,2022,第1期首页上一页 9 10 11 尾页共有11页，转到页

期刊文章列表